help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Washington, C.
Right arrow Articles by Lichy, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Washington, C.
Right arrow Articles by Lichy, J. H.
(American Journal of Pathology. 2000;157:323-329.)
© 2000 American Society for Investigative Pathology


Regular Articles

Loss of Heterozygosity in Fibrocystic Change of the Breast

Genetic Relationship Between Benign Proliferative Lesions and Associated Carcinomas

Constance Washington{dagger}, Fabienne Dalbègue*, Fleurette Abreo{dagger}, Jeffery K. Taubenberger* and Jack H. Lichy*

From the Molecular Pathology Division,*
Department of Cellular Pathology, Armed Forces Institute of Pathology, Washington, D.C.; and the Department of Pathology,{dagger}
Louisiana State University Medical Center, Shreveport, Louisiana

Loss of heterozygosity (LOH), a genetic change frequently detected in cancer, can also occur in benign epithelial foci in the breast. To characterize LOH in benign breast tissue, 32 cases containing the various components of fibrocystic change in the absence of malignancy were studied. Microdissected foci of ductal hyperplasia, apocrine metaplasia, sclerosing adenosis, and morphologically normal terminal duct lobular units (TDLUs) were analyzed for LOH at 14 polymorphic loci representing seven chromosomal arms. LOH was detected in 22% of normal TDLUs (6/27), 17% of adenosis (4/23), 19% of hyperplasia (4/21), and 53% of apocrine metaplasia (10/19) specimens. Because of the high percentage of LOH in apocrine metaplasia in nonneoplastic specimens, the genetic relationship between apocrine metaplasia and cancer was studied in a panel of breast cancer cases. Of 14 examples of apocrine metaplasia adjacent to a carcinoma, seven were found to have LOH with at least one marker. In all seven cases, the tumor and apocrine metaplasia shared LOH at one or more markers. The results demonstrate that LOH occurs frequently in the components of fibrocystic change as well as in normal TDLUs and suggest that foci of apocrine metaplasia can share a genetically altered precursor cell with an associated carcinoma.





This article has been cited by other articles:


Home page
CarcinogenesisHome page
B. Xie, J. L. Freudenheim, S. S. Cummings, B. Singh, H. He, S. E. McCann, K. B. Moysich, and P. G. Shields
Accurate genotyping from paraffin-embedded normal tissue adjacent to breast cancer
Carcinogenesis, February 1, 2006; 27(2): 307 - 310.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. L. Ellsworth, R. E. Ellsworth, B. Love, B. Deyarmin, S. M. Lubert, V. Mittal, J. A. Hooke, and C. D. Shriver
Outer Breast Quadrants Demonstrate Increased Levels of Genomic Instability
Ann. Surg. Oncol., September 1, 2004; 11(9): 861 - 868.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. Tan-Chiu, J. Wang, J. P. Costantino, S. Paik, C. Butch, D. L. Wickerham, B. Fisher, and N. Wolmark
Effects of Tamoxifen on Benign Breast Disease in Women at High Risk for Breast Cancer
J Natl Cancer Inst, February 19, 2003; 95(4): 302 - 307.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. S. Larson, A. de las Morenas, S. R. Bennett, L. A. Cupples, and C. L. Rosenberg
Loss of Heterozygosity or Allele Imbalance in Histologically Normal Breast Epithelium Is Distinct from Loss of Heterozygosity or Allele Imbalance in Co-Existing Carcinomas
Am. J. Pathol., July 1, 2002; 161(1): 283 - 290.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Franco, S.-F. Picard, F. Mege, L. Arnould, and S. Lizard-Nacol
Absence of Genetic Abnormalities in Fibroadenomas of the Breast Determined at p53 Gene Mutations and Microsatellite Alterations
Cancer Res., November 1, 2001; 61(21): 7955 - 7958.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Maitra, I. I. Wistuba, C. Washington, A. K. Virmani, R. Ashfaq, S. Milchgrub, A. F. Gazdar, and J. D. Minna
High-Resolution Chromosome 3p Allelotyping of Breast Carcinomas and Precursor Lesions Demonstrates Frequent Loss of Heterozygosity and a Discontinuous Pattern of Allele Loss
Am. J. Pathol., July 1, 2001; 159(1): 119 - 130.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I.-M. Shih, W. Zhou, S. N. Goodman, C. Lengauer, K. W. Kinzler, and B. Vogelstein
Evidence That Genetic Instability Occurs at an Early Stage of Colorectal Tumorigenesis
Cancer Res., February 1, 2001; 61(3): 818 - 822.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology.